A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma

Published:2019-04-06 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ye Xu¹,Li Cunyan²,Zu Xuyu³,Lin Minglin⁴,Liu Qiang¹,Liu Jianghua³,Xu Guoguo⁵,Chen Zhiyong⁵,Xu Yongliang⁵,Liu Long⁵,Luo Diteng⁴,Cao Zhe⁵,Shi Guiyuan⁵,Feng Zirui⁶,Deng Hongyu¹,Liao Qianjin¹,Cai Chuan⁶,Liao Duan‐Fang⁶,Wang Jing¹,Jin Junfei⁴,Cao Deliang¹⁶

Affiliation:

1. Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Hunan China

2. Department of Laboratory Medicine Hunan Provincial People's Hospital/the First Affiliated Hospital of Hunan Normal University Hunan China

3. Institute of Clinical Medicine the First Affiliated Hospital of University of South China Hunan China

4. Laboratory of Hepatobiliary and Pancreatic Surgery Affiliated Hospital of Guilin Medical University Guangxi China

5. Light of Life Biotechnology Co., Ltd. Hunan China

6. Division of Stem Cell Regulation and Application, State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation) Hunan University of Chinese Medicine Hunan China

Funder

Natural Science Foundation of Guangxi Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30519

Reference45 articles.

1. Symptom Management in Hepatocellular Carcinoma

2. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)